Guangdong Biolight Meditech Co., Ltd. (SHE:300246)
China · Delayed Price · Currency is CNY 19.00
+0.92 (5.09%)
Aug 14, 2026, 3:04 PM CST
SHE:300246 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,095 | 1,095 | 1,060 | 1,194 | 1,184 | 1,091 |
Revenue Growth | 3.29% | 3.29% | -11.18% | 0.87% | 8.49% | -21.85% |
Gross Profit Gross Profit Growth | 281.53 | 281.53 | 277.9 | 380.23 | 355.13 | 355.76 |
Operating Income Operating Income Growth | -16.76 | -16.76 | -65.89 | 37.37 | -6.64 | 72.6 |
Net Income Net Income Growth | -69.43 | -69.43 | -71.44 | -65.19 | 22.13 | 63.79 |
Earnings Per Share EPS Growth | -0.26 | -0.26 | -0.27 | -0.25 | 0.08 | 0.29 |
EPS Growth | - | - | - | - | -70.84% | -81.52% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
industry industry Growth | 735.36 | 776.52 | 765.93 | 705.96 |
Business Business Growth | 312.44 | 401.3 | 397.79 | 368.31 |
Unallocated Other Operating Income Unallocated Other Operating Income Growth | 12.68 | 16.18 | 19.98 | 16.74 |
Total Total Growth | 1,060 | 1,194 | 1,184 | 1,091 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 676.95 | 676.95 | 730.35 | 820.93 | 779.86 | 336.55 |
Total Debt Total Debt Growth | 724.8 | 724.8 | 645.72 | 584.99 | 427.57 | 356.52 |
Net Cash (Debt) Net Cash Growth | -47.86 | -47.86 | 84.63 | 235.94 | 352.29 | -19.97 |
Net Cash Growth | - | - | -64.13% | -33.03% | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.18 | -0.18 | 0.32 | 0.89 | 1.35 | -0.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 90.44 | 90.44 | -8.64 | 129.05 | 140.72 | 80.61 |
Capital Expenditures CapEx Growth | -167.46 | -167.46 | -103.81 | -220.33 | -211.8 | -163.41 |
Free Cash Flow Free Cash Flow Growth | -77.02 | -77.02 | -112.45 | -91.29 | -71.08 | -82.8 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 25.70% | 25.70% | 26.21% | 31.85% | 30.00% | 32.61% |
Operating Margin | -1.53% | -1.53% | -6.21% | 3.13% | -0.56% | 6.65% |
Pretax Margin | -6.97% | -6.97% | -6.71% | -3.87% | 1.87% | 7.14% |
Profit Margin | -6.34% | -6.34% | -6.74% | -5.46% | 1.87% | 5.85% |
FCF Margin | -7.03% | -7.03% | -10.60% | -7.65% | -6.00% | -7.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.100 | - | - | - | 0.133 | 0.133 |
Dividend Per Share Growth | 0% | - | - | - | 0% | -50.02% |
Dividend Yield | 0.55% | - | - | - | 1.25% | 0.94% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | - | 129.62 | 50.04 |
Forward PE | - | 11.58 | 11.58 | 28.92 | 49.88 | 27.14 |
PS Ratio | 4.54 | 1.93 | 1.63 | 2.28 | 2.42 | 2.93 |